Jubilant DraxImage receives approval for 12-Hour shelf-life extension from the U.S. Food and Drug Administration for DRAXIMAGE® MAA
31 oct. 2017 08h45 HE
|
Jubilant DraxImage
Montreal, QC, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a wholly-owned subsidiary of Jubilant Pharma, is pleased to announce the U.S. Food and Drug Administration...